2nd Quarter - Report

TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit including all such provisions in HR 422 "To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 422 (111th)

Copyright/Patent/Trademark CPT

All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009" and HR1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR1260 "The Patent Reform Act of 2009"

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), H.R. 1706 (111th)

Health Issues HCR

Coverage and payment issues for pharmaceuticals under consideration for draft legislation for healthcare reform; issues related to the importation of presecription drugs in amendments to the draft legislation "Affordable Health Choices Act"; issues related to a regulatory pathway and reimbursement for follow on biologics, including such provisions in HR 1548 "Pathway for Biosimilars Act:l issues related to awareness of the company's Access to Medicines Program; all provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'; general issues related to Medicare Part D program

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.Res. 231 (111th), H.R. 1548 (111th)

Medicare/Medicaid MMM

Issues related to the Medicaid program. Medicare Part B Reimbursement

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.